Dow Up 1.13% Nasdaq Up 1.41%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
24.30 Down 0.13(0.53%) 3:59PM EDT
Prev Close:24.43
Open:24.98
Bid:N/A
Ask:27.69 x 200
1y Target Est:38.17
Beta:0.89
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:24.00 - 25.44
52wk Range:18.97 - 32.98
Volume:101,255
Avg Vol (3m):147,006
Market Cap:500.51M
P/E (ttm):27.00
EPS (ttm):0.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXDown 0.53%500.51M
ALXNDown 0.81%37.94B
CPIXUp 1.03%86.13M
SLXPDown 0.45%9.16B

Key Statistics

Forward P/E (1 yr):347.14
P/S (ttm):5.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.54
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a commercial biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases and hepatology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback